DOI QR코드

DOI QR Code

Biodegradable Screws Containing Bone Morphogenetic Protein-2 in an Osteoporotic Rat Model

  • Jin, Eun-Sun (Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Kim, Ji Yeon (Laboratory of Stem Cell Therapy, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Bora (Department of Biostatistic Consulting, Soon Chun Hyang Medical Center) ;
  • Min, JoongKee (Laboratory of Stem Cell Therapy, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jeon, Sang Ryong (Laboratory of Stem Cell Therapy, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Kyoung Hyo (Laboratory of Stem Cell Therapy, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jeong, Je Hoon (Laboratory of Stem Cell Therapy, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2017.11.30
  • Accepted : 2018.02.09
  • Published : 2018.09.01

Abstract

Objective : The aim of this study was to evaluate the effect for biodegradable screws containing bone morphogenetic protein-2 (BMP-2) in an osteoporotic rat model. Methods : Twenty-four female Wistar rat (250-300 g, 12 weeks of age) were randomized into four groups. Three groups underwent bilateral ovariectomy (OVX). Biodegradable screws with or without BMP-2 were inserted in the proximal tibia in two implantation groups. The extracted proximal metaphysis of the tibiae were scanned by exo-vivo micro-computed tomography. Evaluated parameters included bone mineral density (BMD), trabecular bone volume (BV/TV), trabecular number, trabecular thickness, and trabecular separation (Tb.Sp). The tibia samples were pathologically evaluated by staining with by Hematoxylin and Eosin, and trichrome. Results : Trabecular formation near screw insertion site was evident only in rats receiving BMP-2 screws. BMD and BV/TV significantly differed between controls and the OVX and OVX with screw groups. However, there were no significant differences between control and OVX with screw BMP groups. Tb.Sp significantly differed between control and OVX and OVX with screw groups (p<0.05), and between the OVX and OVX with screw BMP group (p<0.05), with no statistically significant difference between control and OVX with screw BMP groups. Over the 12 weeks after surgery, bone lamellae in direct contact with the screw developed more extensive and thicker trabecular bone around the implant in the OVX with screw BMP group compared to the OVX with screw group. Conclusion : Biodegradable screws containing BMP-2 improve nearby bone conditions and enhance ostoeintegration between the implant and the osteoporotic bone.

Keywords

References

  1. Astrand P, Ahlqvist J, Gunne J, Nilson H : Implant treatment of patients with edentulous jaws: a 20-year follow-up. Clin Implant Dent Relat Res 10 : 207-217, 2008
  2. Brown KV, Li B, Guda T, Perrien DS, Guelcher SA, Wenke JC : Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. Tissue Eng Part A 17 : 1735-1746, 2011 https://doi.org/10.1089/ten.tea.2010.0446
  3. Cho TJ, Gerstenfeld LC, Einhorn TA : Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17 : 513-520, 2002 https://doi.org/10.1359/jbmr.2002.17.3.513
  4. Choi H, Park NJ, Jamiyandorj O, Choi KH, Hong MH, Oh S. Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with two concentrations of expressed recombinant human bone morphogenetic protein 2. J Periodontal Implant Sci 42 : 119-126, 2012 https://doi.org/10.5051/jpis.2012.42.4.119
  5. Cowan CM, Aghaloo T, Chou YF, Walder B, Zhang X, Soo C, et al. : MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng 13 : 501-512, 2007 https://doi.org/10.1089/ten.2006.0141
  6. Duarte PM, Cesar Neto JB, Goncalves PF, Sallum EA, Nociti jF : Estrogen deficiency affects bone healing around titanium implants: a histometric study in rats. Implant Dent 12 : 340-346, 2003 https://doi.org/10.1097/01.ID.0000099750.26582.4B
  7. Gao Y, Zou S, Liu X, Bao C, Hu J : The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials 30 : 1790-1796, 2009 https://doi.org/10.1016/j.biomaterials.2008.12.025
  8. Hammerle CH, Olah AJ, Schmid J, Fluckiger L, Gogolewski S, Winkler JR, et al. : The biological effect of natural bone mineral on bone neoformation on the rabbit skull. Clin Oral Implants Res 8 : 198-207, 1997 https://doi.org/10.1034/j.1600-0501.1997.080306.x
  9. Herrmann I, Lekholm U, Holm S, Kultje C : Evaluation of patient and implant characteristics as potential prognostic factors for oral implant failures. Int J Oral Maxillofac Implants 20 : 220-230, 2005
  10. Hyun SJ, Han DK, Choi SH, Chai JK, Cho KS, Kim CK, et al. : Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects. J Periodontol 76 : 1667-1674, 2005 https://doi.org/10.1902/jop.2005.76.10.1667
  11. Jakobsen T, Baas J, Kold S, Bechtold JE, Elmengaard B, Soballe K : Local bisphosphonate treatment increases fixation of hydroxyapatite-coated implants inserted with bone compaction. J Orthop Res 27 : 189-194, 2009 https://doi.org/10.1002/jor.20745
  12. Jung JH, Yun JH, Um YJ, Jung UW, Kim CS, Choi SH, et al. : Bone formation of Escherichia coli expressed rhBMP-2 on absorbable collagen block in rat calvarial defects. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111 : 298-305, 2011 https://doi.org/10.1016/j.tripleo.2010.05.011
  13. Jung UW, Choi SY, Pang EK, Kim CS, Choi SH, Cho KS : The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 77 : 765-772, 2006 https://doi.org/10.1902/jop.2006.050268
  14. Lee S, Choi H, Shim JS, Chung MK, Park YB : Comparative study of recombinant human bone morphogenetic protein-2 carriers in rat subcutaneous tissues: Pilot study. Tissue Eng Regen Med 12 : 138-146, 2015 https://doi.org/10.1007/s13770-015-0437-0
  15. Li Y, Feng G, Gao Y, Luo E, Liu X, Hu J : Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats. J Orthop Res 28 : 578-582, 2010
  16. Liang YQ, Qi MC, Xu J, Xu J, Liu HW, Dong W, et al. : Low-magnitude high-frequency loading, by whole-body vibration, accelerates early implant osseointegration in ovariectomized rats. Mol Med Rep 10 : 2835-2842, 2014 https://doi.org/10.3892/mmr.2014.2597
  17. Lugero GG, de Falco Caparbo V, Guzzo ML, Konig B Jr, Jorgetti V : Histomorphometric evaluation of titanium implants in osteoporotic rabbits. Implant Dent 9 : 303-309, 2000 https://doi.org/10.1097/00008505-200009040-00005
  18. Mellado-Valero A, Ferrer-Garcia JC, Calvo-Catala J, Labaig-Rueda C : Implant treatment in patients with osteoporosis. Med Oral Patol Oral Cir Bucal 15 : e52-e57, 2010
  19. Qi M, Hu J, Li J, Li J, Dong W, Feng X, et al. : Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits. Bone 50 : 119-127, 2012 https://doi.org/10.1016/j.bone.2011.10.011
  20. Qi MC, Zhou XQ, Hu J, Du ZJ, Yang JH, Liu M, et al. : Oestrogen replacement therapy promotes bone healing around dental implants in osteoporotic rats. Int J Oral Maxillofac Surg 33 : 279-285, 2004 https://doi.org/10.1006/ijom.2002.0398
  21. Schmoekel H, Schense JC, Weber FE, Gratz KW, Gnagi D, Muller R, et al. : Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. J Orthop Res 22 : 376-381, 2004 https://doi.org/10.1016/S0736-0266(03)00188-8
  22. Seeherman H, Wozney J, Li R : Bone morphogenetic protein delivery systems. Spine (Phila Pa 1976) 27 : S16-S23, 2002 https://doi.org/10.1097/00007632-200201010-00006
  23. Seeherman H, Wozney JM : Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 16 : 329-345, 2005 https://doi.org/10.1016/j.cytogfr.2005.05.001
  24. Skoglund B, Holmertz J, Aspenberg P : Systemic and local ibandronate enhance screw fixation. J Orthop Res 22 : 1108-1113, 2004 https://doi.org/10.1016/j.orthres.2003.12.015
  25. Skripitz R, Bohling S, Ruther W, Aspenberg P : Stimulation of implant fixation by parathyroid hormone (1-34)-A histomorphometric comparison of PMMA cement and stainless steel. J Orthop Res 23 : 1266-1270, 2005
  26. Tagil M, Jeppsson C, Wang JS, Aspenberg P : No augmentation of morselized and impacted bone graft by OP-1 in a weight-bearing model. Acta Orthop Scand 74 : 742-748, 2003 https://doi.org/10.1080/00016470310018306
  27. Urist MR : Bone morphogenetic protein: the molecularization of skeletal system development. J Bone Miner Res 12 : 343-346, 1997 https://doi.org/10.1359/jbmr.1997.12.3.343
  28. Wen B, Karl M, Pendrys D, Shafer D, Freilich M, Kuhn L : An evaluation of BMP-2 delivery from scaffolds with miniaturized dental implants in a novel rat mandible model. J Biomed Mater Res B Appl Biomater 97 : 315-326, 2011
  29. Wikesjo UM, Guglielmoni P, Promsudthi A, Cho KS, Trombelli L, Selvig KA, et al. : Periodontal repair in dogs: effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 26 : 392-400, 1999 https://doi.org/10.1034/j.1600-051X.1999.260610.x
  30. Yamaguchi K, Masuhara K, Yamasaki S, Nakai T, Fuji T : Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty. Bone 33 : 144-149, 2003 https://doi.org/10.1016/S8756-3282(03)00085-1
  31. Yamazaki Y, Oida S, Akimoto Y, Shioda S : Response of the mouse femoral muscle to an implant of a composite of bone morphogenetic protein and plaster of Paris. Clin Orthop Relat Res (234) : 240-249, 1988
  32. Zheng LW, Wong MC, Rabie AB, Cheung LK : Evaluation of recombinant human bone morphogenetic protein-2 in mandibular distraction osteogenesis in rabbits: effect of dosage and number of doses on formation of bone. Br J Oral Maxillofac Surg 44 : 487-494, 2006 https://doi.org/10.1016/j.bjoms.2005.09.005
  33. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94 : 646-650, 1993 https://doi.org/10.1016/0002-9343(93)90218-E